Log In
BCIQ
Print this Print this
 

midazolam (NVD-301)

  Manage Alerts
Collapse Summary General Information
Company Suda Ltd.
DescriptionOral spray formulation of midazolam
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAnxiety
Indication DetailsTreat pre-procedure anxiety
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1.8M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/07/2013

$1.8M

Undisclosed

Undisclosed

Get a free BioCentury trial today